Evaluating Hallucinogenic or Psychedelic Drug Intoxication in an Emergency Setting
Robert H. Williams, T. Erickson
July 1, 2000 DOI: 10.1309/v3j8-3kw2-bpt1-fu15 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Qualitative |
|---|---|
| Key findings | Diagnosis of hallucinogen ingestion often depends on history and physical exam because standard drug screens miss many hallucinogens. |
Abstract
Under certain conditions or in an overdose setting, several classes of drugs can induce illusions, hallucinations, or delusions. However, one of the hallmark features of hallucinogens or psychedelic agents is their ability to induce states of altered or distorted perception, thought, and mood. Many hallucinogens produce classic sympathomimetic effects; that is, hyperactivity, mydriasis (dilated pupils), hypertension, tachycardia, and hyperthermia. However, the effects vary considerably, depending upon the hallucinogen ingested. Qualitative confirmation by the laboratory that the patient is suffering from hallucinogen intoxication such as marijuana use can be helpful to the clinician. However, the common toxicologic drug screens used by most clinical laboratories do not detect many hallucinogenic agents (such as LSD [lysergic acid diethylamide]). Thus, diagnosis of hallucinogen ingestion and treatment is often based on history of use and physical examination.
Citations in the library
Cited by 2
Cites 12
- Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. Life Sciences December 17, 1984
- Bufo alvarius: a potent hallucinogen of animal origin. Journal of Ethnopharmacology 1994
- Hallucinogenic Drugs in Psychiatric Research and Treatment Perspectives and Prospects The Journal of Nervous and Mental Disease March 1, 1995
- Lysergic Acid Diethylamide New England Journal of Medicine February 22, 1968
- Hallucinogenic Mushrooms Clinical Pediatrics February 1, 1988
and 7 more in the library